Immediate Impact
57 standout
Citing Papers
Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements
2024 Standout
Trials and Tribulations of MicroRNA Therapeutics
2024 Standout
Works of Ruifen Dong being referenced
Upregulated MELK Leads to Doxorubicin Chemoresistance and M2 Macrophage Polarization via the miR-34a/JAK2/STAT3 Pathway in Uterine Leiomyosarcoma
2020
Histologic and molecular analysis of patient derived xenografts of high-grade serous ovarian carcinoma
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Ruifen Dong | 407 | 351 | 109 | 167 | 22 | 662 | |
| Todd Boren | 415 | 322 | 114 | 110 | 20 | 614 | |
| Chunping Qiu | 422 | 276 | 119 | 121 | 31 | 722 | |
| Olga Camacho‐Vanegas | 553 | 283 | 123 | 105 | 25 | 844 | |
| Dilu Feng | 365 | 217 | 179 | 110 | 25 | 630 | |
| Yanchun Liang | 347 | 314 | 60 | 137 | 24 | 613 | |
| Zhihong Ai | 417 | 273 | 110 | 62 | 23 | 627 | |
| Wenxiao Jiang | 450 | 273 | 162 | 90 | 28 | 783 | |
| Chi‐Mu Chuang | 376 | 309 | 177 | 129 | 19 | 766 | |
| Qing Yang | 410 | 187 | 189 | 149 | 29 | 724 | |
| Mingzi Tan | 333 | 174 | 124 | 145 | 27 | 606 |
All Works
Login with ORCID to disown or claim papers
Loading papers...